In a CD133+ HCC cell line (HepG2 and Huh7), osthole reestablished sensitivity to cisplatin treatment with mitochondrial apoptosis expanding via the PTEN/AKT pathway. This evidence concerns the gene PROM1 and hepatocellular carcinoma.